Follow
Nabanita Nawar
Nabanita Nawar
Verified email at mail.utoronto.ca - Homepage
Title
Cited by
Cited by
Year
Student coaching: How far can technology go?
P Oreopoulos, U Petronijevic
Journal of Human Resources 53 (2), 299-329, 2018
1672018
Can genetically based clines in plant defence explain greater herbivory at higher latitudes?
DN Anstett, JR Ahern, J Glinos, N Nawar, JP Salminen, MTJ Johnson
Ecology letters 18 (12), 1376-1386, 2015
662015
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia
JM Gawel, AE Shouksmith, YS Raouf, N Nawar, K Toutah, S Bukhari, ...
European Journal of Medicinal Chemistry, 112411, 2020
362020
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting
MM Hassan, J Israelian, N Nawar, G Ganda, P Manaswiyoungkul, ...
Journal of Medicinal Chemistry, 2020
322020
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
K Toutah, N Nawar, S Timonen, H Sorger, YS Raouf, S Bukhari, J von Jan, ...
Journal of Medicinal Chemistry, 2021
282021
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia
AE Shouksmith, JM Gawel, N Nawar, D Sina, YS Raouf, S Bukhari, L He, ...
ACS Medicinal Chemistry Letters 11 (1), 56-64, 2019
242019
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
N Nawar, S Bukhari, AA Adile, Y Suk, P Manaswiyoungkul, K Toutah, ...
Journal of Medicinal Chemistry, 2022
182022
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype
OO Olaoye, PR Watson, N Nawar, M Geletu, A Sedighi, S Bukhari, ...
Journal of Medicinal Chemistry 64 (5), 2691-2704, 2021
172021
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma
HK Garcha, N Nawar, H Sorger, F Erdogan, MMK Aung, A Sedighi, ...
Pharmaceuticals 15 (11), 1321, 2022
2022
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches
N Nawar, HK Garcha, A Sedighi, ED de Araujo, PT Gunning
HDAC/HAT Function Assessment and Inhibitor Development: Methods and …, 2022
2022
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lym
HK Garcha, N Nawar, H Sorger, F Erdogan, MMK Aung, A Sedighi, ...
Pharmaceutics 15 (11)), 2022
2022
Halogenated phenylsulfonamide hydroxamic acid compounds, compositions and uses thereof as selective hdac6 inhibitors
PT Gunning, O Olaoye, K Toutah, AE Shouksmith, JM Shouksmith, ...
US Patent App. 17/593,877, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–12